Científicos descubren cómo el receptor de colesterol ayuda al virus de la hepatitis A a entrar en las células

This groundbreaking study solves a decades-old puzzle about how hepatitis A virus infects human cells, potentially opening new avenues for antiviral drug development and improving our understanding of viral infections.

Researchers investigated hepatitis A virus, which exists in two forms: non-enveloped particles shed in feces and quasi-enveloped particles in blood. While scientists knew how the blood form entered cells, the mechanism for the fecal form remained unknown.

Using knockout cell lines, advanced electron microscopy, and binding assays, scientists tested whether the low-density lipoprotein receptor (LDLR) - famous for cholesterol metabolism - might serve as an entry point. They created cells lacking LDLR and tested viral infection rates.

The results were striking: LDLR knockout completely blocked non-enveloped hepatitis A virus entry without affecting viral attachment. Restoring LDLR expression rescued viral entry, while blocking LDLR with antibodies or soluble receptor fragments prevented infection. High-resolution imaging revealed the virus binds to specific regions of LDLR.

This discovery has significant implications for antiviral drug development, as LDLR could become a therapeutic target. Understanding viral entry mechanisms also advances our knowledge of how pathogens exploit normal cellular processes. However, the research was conducted in laboratory cell cultures, and real-world applications require further study. The findings primarily apply to hepatitis A prevention rather than longevity enhancement, though they contribute to our broader understanding of cellular biology and infection prevention strategies.